| 摘要 |
<p>A process for the preparation of (-)eburnamenin-14-(15H)-one resinates having improved pharmacological properties. These resinates are prepared by reacting phosphate or any addition salts of (-)eburnamenin-14-(15H)-one with an alkali metal sulphonate type cationic resin, in a polar solvent for 10 hours at 50 DEG C. under stirring.</p> |
